Short answer
Pediatrix Medical Group, Inc. (MD) filed an 8-K current report with the SEC on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter results announcement for the three and nine months ended September 30, 2026.
Pediatrix Medical Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter results announcement for the three and nine months ended September 30, 2026
- Press release dated October 29, 2026, contains operating results and financial details
- Exhibit 99.1 is the key source for revenue, earnings, cash flow and outlook metrics
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $501.4M, up 1.7%, with same-unit growth 0.6% and acquisitions contributing 1.1%
- Adjusted EPS $0.72 versus $0.67, despite GAAP EPS declining to $0.59 from $0.84
- Adjusted EBITDA $85.5M versus $87.3M, signaling expense pressure at existing units despite acquisition benefits
- Nine-month Adjusted EBITDA $220.1M versus $209.7M, supporting full-year guidance of $290M to $300M
- $83.0M share repurchases reduced diluted shares to 79.7M, while cash fell to $311.9M and debt stood at $578M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pediatrix Medical Group, Inc. 8-K filings
Get the next MD 8-K as it lands
Follow MD for push alerts, or ask the research agent what this filing means.